B cell immunopathology during HIV-1 infection: Lessons to learn for HIV-1 vaccine design

被引：45

作者：

Cagigi, Alberto ^{[1
]}

Nilsson, Anna ^{[1
,2
]}

De Milito, Angelo ^{[3
]}

Chiodi, Francesca ^{[1
]}

机构：

[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden

[2] Karolinska Inst, Dept Woman & Child Hlth, Stockholm, Sweden

[3] Ist Super Sanita, Dept Drug Res & Evaluat, I-00161 Rome, Italy

来源：

VACCINE | 2008年 / 26卷 / 24期

关键词：

B cells; HIV-1; vaccination; chemokine receptors;

D O I：

10.1016/j.vaccine.2007.11.063

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Induction of broad HIV-1 neutralizing antibodies should be a major goal of an effective HIV-1 vaccine. However, B cells are severely damaged during HIV-1 infection with loss of memory B cells and decline of serological. memory. The molecular events leading to B cell damage must be further characterized with the aim of selecting vaccine components allowing preservation of B cell functions. This review focuses on B cell damage and antibody responses in HIV-1-infected patients during vaccination studies with viral and bacterial. antigens. In addition novel data indicate that B cell activation may be at the basis of impaired immune responses. (c) 2007 Elsevier Ltd. All rights reserved.

引用

收藏

页码：3016 / 3025

页数：10

相关论文

共 93 条

[71] Humoral response against Cryptococcus neoformans mannoprotein antigens in HIV-infected patients [J].

Pitzurra, L ;

Perito, S ;

Baldelli, F ;

Bistoni, F ;

Vecchiarelli, A .

CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 133 (01) :91-96

[72] Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells [J].

Qiao, XG ;

He, B ;

Chiu, A ;

Knowles, DM ;

Chadburn, A ;

Cerutti, A .

NATURE IMMUNOLOGY, 2006, 7 (03) :302-310

[73] Loss of IL-7Rα is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients [J].

Rethi, B ;

Fluur, C ;

Atlas, A ;

Krzyzowska, M ;

Mowafi, F ;

Grützmeier, S ;

De Milito, A ;

Bellocco, R ;

Falk, KI ;

Rajnavölgyi, É ;

Chiodi, F .

AIDS, 2005, 19 (18) :2077-2086

[74] ANTIBODY TO CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS-PNEUMONIAE AFTER VACCINATION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED SUBJECTS WITH 23-VALENT PNEUMOCOCCAL VACCINE [J].

RODRIGUEZBARRADAS, MC ;

MUSHER, DM ;

LAHART, C ;

LACKE, C ;

GROOVER, J ;

WATSON, D ;

BAUGHN, R ;

CATE, T ;

CROFOOT, G .

JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03) :553-556

[75] IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: Persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response [J].

RodriguezBarradas, MC ;

Groover, JE ;

Lacke, CE ;

Gump, DW ;

Lahart, CJ ;

Pandey, JP ;

Musher, DM .

JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (06) :1347-1353

[76] The dynamics of the B follicle: understanding the normal counterpart of B-cell-derived malignancies [J].

Sagaert, X. ;

Sprangers, B. ;

De Wolf-Peeters, C. .

LEUKEMIA, 2007, 21 (07) :1378-1386

[77] Classification of B-cells according to their differentiation status, their micro-anatomical localisation and their developmental lineage [J].

Sagaert, X ;

De Wolf-Peeters, C .

IMMUNOLOGY LETTERS, 2003, 90 (2-3) :179-186

[78] Neonatal measles immunity in rural Kenya: The influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples [J].

Scott, S ;

Cumberland, P ;

Shulman, CE ;

Cousens, S ;

Cohen, BJ ;

Brown, DWG ;

Bulmer, JN ;

Dorman, EK ;

Kawuondo, K ;

Marsh, K ;

Cutts, F .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (11) :1854-1860

[79] Humoral immunity due to long-lived plasma cells [J].

Slifka, MK ;

Antia, R ;

Whitmire, JK ;

Ahmed, R .

IMMUNITY, 1998, 8 (03) :363-372

[80] Qualitative change in antibody responses of human immunodeficiency virus-infected individuals to pneumococcal capsular polysaccharide vaccination associated with highly active antiretroviral therapy [J].

Subramaniam, KS ;

Segal, R ;

Lyles, RH ;

Rodriguez-Barradas, MC ;

Pirofski, LA .

JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (05) :758-768

← 1 2 3 4 5 6 7 8 9 10 →